1. a b Tawab MA, et al. Development of a high-performance liquid chromatographic method for the determination of 11-keto-beta-boswellic acid in human plasmaJ Chromatogr B Biomed Sci Appl. (2001)
  2. ^ Woolley CL, et al. Chemical differentiation of Boswellia sacra and Boswellia carterii essential oils by gas chromatography and chiral gas chromatography-mass spectrometryJ Chromatogr A. (2012)
  3. ^ de Rapper S, et al. The additive and synergistic antimicrobial effects of select frankincense and myrrh oils–a combination from the pharaonic pharmacopoeiaLett Appl Microbiol. (2012)
  4. ^ Blain EJ, Ali AY, Duance VC. Boswellia frereana (frankincense) suppresses cytokine-induced matrix metalloproteinase expression and production of pro-inflammatory molecules in articular cartilagePhytother Res. (2010)
  5. ^ Devi PR, et al. Safety Evaluation of Alcoholic Extract of Boswellia ovalifoliolata Stem-bark in RatsToxicol Int. (2012)
  6. a b c Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overviewIndian J Pharm Sci. (2011)
  7. a b c d e f g h Gerbeth K, et al. Determination of major boswellic acids in plasma by high-pressure liquid chromatography/mass spectrometryJ Pharm Biomed Anal. (2011)
  8. a b c d e f g h i j k l Moussaieff A, et al. Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brainFASEB J. (2008)
  9. ^ Al-Harrasi A, Al-Saidi S. Phytochemical analysis of the essential oil from botanically certified oleogum resin of Boswellia sacra (Omani Luban)Molecules. (2008)
  10. a b Wang C, et al. Determination of five boswellic acids in Boswellia serrataZhongguo Zhong Yao Za Zhi. (2011)
  11. a b c Büchele B, Simmet T. Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detectionJ Chromatogr B Analyt Technol Biomed Life Sci. (2003)
  12. a b c d e f g h Moussaieff A, et al. Incensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animalsJ Psychopharmacol. (2012)
  13. ^ Paul M, Jauch J. Efficient preparation of incensole and incensole acetate, and quantification of these bioactive diterpenes in Boswellia papyrifera by a RP-DAD-HPLC methodNat Prod Commun. (2012)
  14. a b c Bhushan S, et al. A triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cellsApoptosis. (2007)
  15. a b c Bhushan S, et al. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrataMol Carcinog. (2009)
  16. ^ Schmidt TJ, Kaiser M, Brun R. Complete structural assignment of serratol, a cembrane-type diterpene from Boswellia serrata, and evaluation of its antiprotozoal activityPlanta Med. (2011)
  17. ^ Two triterpenoids from Boswellia serrata gum resin.
  19. ^ Song Z, et al. Determination of alpha-pinene and octyl acetate contents in Boswellia serrataZhongguo Zhong Yao Za Zhi. (2012)
  20. a b c d e f Khajuria A, et al. Immunomodulatory activity of biopolymeric fraction BOS 2000 from Boswellia serrataPhytother Res. (2008)
  21. ^ The structure of incensole.
  22. a b c d Roy S, et al. Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory BoswelliaAntioxid Redox Signal. (2006)
  23. ^ Sengupta K, et al. Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extractMol Cell Biochem. (2011)
  24. a b c d e f g Takada Y, et al. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expressionJ Immunol. (2006)
  25. ^ Kumar A, et al. Nuclear factor-kappaB: its role in health and diseaseJ Mol Med (Berl). (2004)
  26. ^ Ozes ON, et al. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinaseNature. (1999)
  27. ^ Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzleCell. (2002)
  28. ^ Nakayama T, Sawada T. Involvement of microtubule integrity in memory impairment caused by colchicinePharmacol Biochem Behav. (2002)
  29. ^ Trojanowski JQ, et al. Microtubule-stabilising drugs for therapy of Alzheimer’s disease and other neurodegenerative disorders with axonal transport impairmentsExpert Opin Pharmacother. (2005)
  30. ^ Nelson R. Microtubule-stabilising drugs may be therapeutic in ADLancet Neurol. (2005)
  31. ^ Avila J, et al. Role of tau protein in both physiological and pathological conditionsPhysiol Rev. (2004)
  32. a b Karima O, et al. An in vitro study of the role of β-boswellic acid in the microtubule assembly dynamicsFEBS Lett. (2012)
  33. a b Karima O, et al. The enhancement effect of beta-boswellic acid on hippocampal neurites outgrowth and branching (an in vitro study)Neurol Sci. (2010)
  34. ^ Krüger P, et al. Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2Eur J Pharm Sci. (2009)
  35. ^ Krishna G, et al. Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2Int J Pharm. (2001)
  36. a b c d e f g h Gerbeth K, et al. In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resinsFitoterapia. (2012)
  37. a b c d e f g h i Hüsch J, et al. Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome®) of Boswellia extractFitoterapia. (2012)
  38. ^ Hüsch J, et al. Effect of Phospholipid-Based Formulations of Boswellia serrata Extract on the Solubility, Permeability, and Absorption of the Individual Boswellic Acid Constituents PresentJ Nat Prod. (2012)
  39. ^ Sharma A, Gupta NK, Dixit VK. Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acidDrug Deliv. (2010)
  40. a b c Reising K, et al. Determination of boswellic acids in brain and plasma by high-performance liquid chromatography/tandem mass spectrometryAnal Chem. (2005)
  41. a b c Tausch L, et al. Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincenseJ Immunol. (2009)
  42. ^ Sterk V, Büchele B, Simmet T. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteersPlanta Med. (2004)
  43. a b c d Skarke C, et al. Increased bioavailability of 11-keto-β-boswellic acid following single oral dose frankincense extract administration after a standardized meal in healthy male volunteers: modeling and simulation considerations for evaluating drug exposuresJ Clin Pharmacol. (2012)
  44. a b Siemoneit U, et al. On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevanceEur J Pharmacol. (2009)
  45. ^ Krüger P, et al. Metabolism of boswellic acids in vitro and in vivoDrug Metab Dispos. (2008)
  46. ^ Weber CC, et al. Modulation of Pgp function by boswellic acidsPlanta Med. (2006)
  47. ^ Chung MK, et al. TRPV3 and TRPV4 mediate warmth-evoked currents in primary mouse keratinocytesJ Biol Chem. (2004)
  48. ^ Xu H, et al. TRPV3 is a calcium-permeable temperature-sensitive cation channelNature. (2002)
  49. ^ Smith GD, et al. TRPV3 is a temperature-sensitive vanilloid receptor-like proteinNature. (2002)
  50. a b Bakthira H, et al. Anticholinesterase activity of endemic plant extracts from SoqotraAfr J Tradit Complement Altern Med. (2011)
  51. a b c Moussaieff A, et al. Protective effects of incensole acetate on cerebral ischemic injuryBrain Res. (2012)
  52. a b c Streffer JR, et al. Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15Neurology. (2001)
  53. a b c Winking M, et al. Boswellic acids inhibit glioma growth: a new treatment optionJ Neurooncol. (2000)
  54. ^ Lampl C, Haider B, Schweiger C. Long-term efficacy of Boswellia serrata in four patients with chronic cluster headacheCephalalgia. (2012)
  55. ^ Leroux E, Ducros A. Cluster headacheOrphanet J Rare Dis. (2008)
  56. a b Mahmoudi A, et al. Evaluation of systemic administration of Boswellia papyrifera extracts on spatial memory retention in male ratsJ Nat Med. (2011)
  57. ^ Roy S, et al. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cellsDNA Cell Biol. (2005)
  58. a b c Cuaz-Pérolin C, et al. Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- miceArterioscler Thromb Vasc Biol. (2008)
  59. a b c d e f g h Sengupta K, et al. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical studyInt J Med Sci. (2010)
  60. ^ The IκB Kinase (IKK) Inhibitor, NEMO-binding Domain Peptide, Blocks Osteoclastogenesis and Bone Erosion in Inflammatory Arthritis.
  61. ^ Abu-Amer Y, Tondravi MM. NF-kappaB and bone: the breaking pointNat Med. (1997)
  62. ^ Kulkarni RR, et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over studyJ Ethnopharmacol. (1991)
  63. ^ Chopra A, et al. Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritisJ Rheumatol. (2000)
  64. a b Vishal AA, Mishra A, Raychaudhuri SP. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of kneeInt J Med Sci. (2011)
  65. a b Sengupta K, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the kneeArthritis Res Ther. (2008)
  66. a b Gupta PK, et al. Clinical evaluation of Boswellia serrata (Shallaki) resin in the management of Sandhivata (osteoarthritis)Ayu. (2011)
  67. ^ Chrubasik JE, Roufogalis BD, Chrubasik S. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back painPhytother Res. (2007)
  68. ^ Cassileth B. Complementary therapies, herbs, and other OTC agents: Boswellia (Boswellia serrata)Oncology (Williston Park). (2009)
  69. ^ Martínez-Clemente M, Clària J, Titos E. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver diseaseCurr Opin Clin Nutr Metab Care. (2011)
  70. ^ Gupta I, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitisEur J Med Res. (1997)
  71. a b Sailer ER, et al. Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activityBr J Pharmacol. (1996)
  72. ^ Safayhi H, et al. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenaseJ Pharmacol Exp Ther. (1992)
  73. ^ Safayhi H, Sailer ER, Ammon HP. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acidMol Pharmacol. (1995)
  74. ^ Ammon HP, et al. Mechanism of antiinflammatory actions of curcumine and boswellic acidsJ Ethnopharmacol. (1993)
  75. ^ Siemoneit U, et al. Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acidsBiochem Pharmacol. (2008)
  76. a b c d Ammon HP. Modulation of the immune system by Boswellia serrata extracts and boswellic acidsPhytomedicine. (2010)
  77. ^ Poeckel D, Werz O. Boswellic acids: biological actions and molecular targetsCurr Med Chem. (2006)
  78. ^ Inhibition of IκB Kinase Activity by Acetyl-boswellic Acids Promotes Apoptosis in Androgen-independent PC-3 Prostate Cancer Cells in Vitro and in Vivo.
  79. a b Acetyl-Boswellic Acids Inhibit Lipopolysaccharide-Mediated TNF-α Induction in Monocytes by Direct Interaction with IκB Kinases.
  80. a b c d e Henkel A, et al. Boswellic acids from frankincense inhibit lipopolysaccharide functionality through direct molecular interferenceBiochem Pharmacol. (2012)
  81. ^ Morrison DC, Jacobs DM. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharidesImmunochemistry. (1976)
  82. ^ Moussaieff A, et al. Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activationMol Pharmacol. (2007)
  83. ^ Pham CT. Neutrophil serine proteases: specific regulators of inflammationNat Rev Immunol. (2006)
  84. a b Siemoneit U, et al. Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincenseBr J Pharmacol. (2011)
  85. ^ Samuelsson B, Morgenstern R, Jakobsson PJ. Membrane prostaglandin E synthase-1: a novel therapeutic targetPharmacol Rev. (2007)
  86. ^ Verhoff M, et al. A novel C(28)-hydroxylated lupeolic acid suppresses the biosynthesis of eicosanoids through inhibition of cytosolic phospholipase A(2)Biochem Pharmacol. (2012)
  87. a b c Safayhi H, et al. Inhibition by boswellic acids of human leukocyte elastaseJ Pharmacol Exp Ther. (1997)
  88. a b Kapil A, Moza N. Anticomplementary activity of boswellic acids–an inhibitor of C3-convertase of the classical complement pathwayInt J Immunopharmacol. (1992)
  89. a b c d e Immunomodulatory Activity of Boswellic Acids (Pentacyclic Triterpene Acids) from Boswellia serrata.
  90. ^ Khajuria A, et al. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAgVaccine. (2007)
  91. a b Immunomodulatory Triterpenoids from the Oleogum Resin of Boswellia carterii Birdwood.
  92. a b Shehata AM, et al. Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE)Phytomedicine. (2011)
  93. a b c d e Yuan HQ, et al. Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cellsBiochem Pharmacol. (2008)
  94. ^ Rollinger JM, et al. 11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approachesBioorg Med Chem. (2010)
  95. a b Borrelli F, et al. Effect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhoea without constipationBr J Pharmacol. (2006)
  96. a b Latella G, et al. Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acidEur J Clin Invest. (2008)
  97. ^ Ke F, Yadav PK, Ju LZ. Herbal medicine in the treatment of ulcerative colitisSaudi J Gastroenterol. (2012)
  98. a b Hartmann RM, et al. Effect of Boswellia serrata on antioxidant status in an experimental model of colitis rats induced by acetic acidDig Dis Sci. (2012)
  99. a b Anthoni C, et al. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitisAm J Physiol Gastrointest Liver Physiol. (2006)
  100. ^ Rhodes JM, et al. Serum inhibitors of leukocyte chemotaxis in Crohn’s disease and ulcerative colitisGastroenterology. (1982)
  101. ^ Chande N, McDonald JW, Macdonald JK. Interventions for treating collagenous colitisCochrane Database Syst Rev. (2008)
  102. ^ Madisch A, et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trialInt J Colorectal Dis. (2007)
  103. ^ Slonim AE, Grovit M, Bulone L. Effect of exclusion diet with nutraceutical therapy in juvenile Crohn’s diseaseJ Am Coll Nutr. (2009)
  104. a b c Holtmeier W, et al. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn’s disease: good safety profile but lack of efficacyInflamm Bowel Dis. (2011)
  105. a b Raja AF, et al. Acetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogensBMC Res Notes. (2011)
  106. ^ Schillaci D, et al. In vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oilsLett Appl Microbiol. (2008)
  107. a b Mahmoud MF, Diaai AA, Ahmed F. Evaluation of the efficacy of ginger, Arabic gum, and Boswellia in acute and chronic renal failureRen Fail. (2012)
  108. ^ Gupta I, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical studyEur J Med Res. (1998)
  109. ^ Clark CE, et al. Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysisPrim Care Respir J. (2010)
  110. a b Houssen ME, et al. Natural anti-inflammatory products and leukotriene inhibitors as complementary therapy for bronchial asthmaClin Biochem. (2010)
  111. a b Lakka A, et al. Isolation of hypoxia-inducible factor 1 (HIF-1) inhibitors from frankincense using a molecularly imprinted polymerInvest New Drugs. (2011)
  112. ^ Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expressionFASEB J. (2002)
  113. ^ Belozerov VE, Van Meir EG. Hypoxia inducible factor-1: a novel target for cancer therapyAnticancer Drugs. (2005)
  114. a b c d e f Pang X, et al. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesisCancer Res. (2009)
  115. a b c Hoernlein RF, et al. Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase IJ Pharmacol Exp Ther. (1999)
  116. ^ Castelli S, et al. Interaction between natural compounds and human topoisomerase IBiol Chem. (2012)
  117. ^ On the expression and regulation of 5-lipoxygenase in human lymphocytes.
  118. a b c d Glaser T, et al. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivityBr J Cancer. (1999)
  119. ^ Glioblastoma multiforme: Morphology and biology.
  120. a b Flavin DF. A lipoxygenase inhibitor in breast cancer brain metastasesJ Neurooncol. (2007)
  121. ^ Shen Y, et al. Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cellsCancer Biol Ther. (2012)
  122. a b Takahashi M, et al. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA familyCarcinogenesis. (2012)
  123. ^ Liu JJ, Duan RD. LY294002 enhances boswellic acid-induced apoptosis in colon cancer cellsAnticancer Res. (2009)
  124. ^ Liu HP, et al. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) miceInt J Cancer. (2012)
  125. ^ Suh J, et al. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cellsProstate. (2002)
  126. ^ Büchele B, et al. Characterization of 3alpha-acetyl-11-keto-alpha-boswellic acid, a pentacyclic triterpenoid inducing apoptosis in vitro and in vivoPlanta Med. (2006)
  127. ^ Lu M, et al. Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cellsCancer Res. (2008)
  128. ^ Kim HR, et al. Bosellia serrata-induced apoptosis is related with ER stress and calcium releaseGenes Nutr. (2008)
  129. ^ Khan S, et al. A cyano analogue of boswellic acid induces crosstalk between p53/PUMA/Bax and telomerase that stages the human papillomavirus type 18 positive HeLa cells to apoptotic deathEur J Pharmacol. (2011)
  130. ^ Kaur R, et al. A comparative study of proapoptotic potential of cyano analogues of boswellic acid and 11-keto-boswellic acidEur J Med Chem. (2011)
  131. a b Aggarwal BB, et al. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solutionAnn N Y Acad Sci. (2006)
  132. ^ Epidermal Growth Factor Receptor Cooperates with Signal Transducer and Activator of Transcription 3 to Induce Epithelial-Mesenchymal Transition in Cancer Cells via Up-regulation of TWIST Gene Expression.
  133. a b c d Kunnumakkara AB, et al. Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1Mol Cancer Res. (2009)
  134. ^ Gene Silencing of the Tyrosine Phosphatase SHP1 Gene by Aberrant Methylation in Leukemias/Lymphomas.
  135. a b c d e f g Park B, et al. Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expressionInt J Cancer. (2011)
  136. ^ Suhail MM, et al. Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cellsBMC Complement Altern Med. (2011)
  137. ^ Mothana RA, et al. Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island SoqotraBMC Complement Altern Med. (2009)
  138. ^ Koshiba T, et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progressionClin Cancer Res. (2000)
  139. a b c d e Park B, et al. Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targetsPLoS One. (2011)
  140. ^ Ni X, et al. Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine modelBMC Complement Altern Med. (2012)
  141. ^ Safayhi H, Sailer ER. Anti-inflammatory actions of pentacyclic triterpenesPlanta Med. (1997)
  142. a b c Pedretti A, et al. Effects of topical boswellic acid on photo and age-damaged skin: clinical, biophysical, and echographic evaluations in a double-blind, randomized, split-face studyPlanta Med. (2010)
  143. a b Calzavara-Pinton P, et al. Topical Boswellic acids for treatment of photoaged skinDermatol Ther. (2010)
  144. a b Krishnaraju AV, et al. Safety and toxicological evaluation of Aflapin: a novel Boswellia-derived anti-inflammatory productToxicol Mech Methods. (2010)
  145. ^ Tripathi YB. BHUx: a patented polyherbal formulation to prevent hyperlipidemia and atherosclerosisRecent Pat Inflamm Allergy Drug Discov. (2009)
  146. a b c d Su S, et al. Evaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha, and Boswellia carteriiJ Ethnopharmacol. (2012)
  147. a b Sferra R, et al. Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulationEur Rev Med Pharmacol Sci. (2012)
  148. a b Lalithakumari K, et al. Safety and Toxicological Evaluation of a Novel, Standardized 3-O-Acetyl-11-keto-beta-Boswellic Acid (AKBA)-Enriched Boswellia serrata Extract (5-Loxin(R))Toxicol Mech Methods. (2006)
  149. ^ Lupi S, et al. Mutagenicity evaluation with Ames test of hydro-alcoholic solution of terpenesJ Prev Med Hyg. (2009)
  150. ^ Sharma R, et al. In vivo genotoxicity evaluation of a plant based antiarthritic and anticancer therapeutic agent Boswelic acids in rodentsPhytomedicine. (2009)
  151. ^ Acebo E, et al. Allergic contact dermatitis from Boswellia serrata extract in a naturopathic creamContact Dermatitis. (2004)